Your browser doesn't support javascript.
loading
Airway mucins promote immunopathology in virus-exacerbated chronic obstructive pulmonary disease.
Singanayagam, Aran; Footitt, Joseph; Marczynski, Matthias; Radicioni, Giorgia; Cross, Michael T; Finney, Lydia J; Trujillo-Torralbo, Maria-Belen; Calderazzo, Maria; Zhu, Jie; Aniscenko, Julia; Clarke, Thomas B; Molyneaux, Philip L; Bartlett, Nathan W; Moffatt, Miriam F; Cookson, William O; Wedzicha, Jadwiga; Evans, Christopher M; Boucher, Richard C; Kesimer, Mehmet; Lieleg, Oliver; Mallia, Patrick; Johnston, Sebastian L.
Afiliação
  • Singanayagam A; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Footitt J; Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
  • Marczynski M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Radicioni G; School of Engineering and Design, Department of Materials Engineering and.
  • Cross MT; Center for Protein Assemblies, Technical University of Munich, Munich, Germany.
  • Finney LJ; Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Trujillo-Torralbo MB; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Calderazzo M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Zhu J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Aniscenko J; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Clarke TB; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Bartlett NW; Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom.
  • Moffatt MF; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Cookson WO; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Wedzicha J; College of Health, Medicine and Wellbeing, Hunter Medical Research Institute and University of Newcastle, Newcastle, New South Wales, Australia.
  • Evans CM; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Boucher RC; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Kesimer M; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
  • Lieleg O; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
  • Mallia P; Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Johnston SL; Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
J Clin Invest ; 132(8)2022 04 15.
Article em En | MEDLINE | ID: mdl-35239513
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Mucina-5AC Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Pulmonar Obstrutiva Crônica / Mucina-5AC Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article